Clinical Trial Update: Enteral Vancomycin as Primary Prophylaxis Against Clostridioides Difficile Infection in Critically Ill Patients [Phase 2, Phase 3]

View source ↗

Summary

Status update for a Phase 2/Phase 3 clinical trial evaluating enteral vancomycin as primary prophylaxis to prevent Clostridioides difficile infection in critica…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clostridioides Difficile Infection
• Vancomycin-resistant Enterococcus Infection

Drugs mentioned

• Vancomycin (vancomycin)

Snippet

Sponsor: Riverside University Health System Medical Center | Conditions: Clostridium Difficile Infection, Vancomycin Resistant Enterococci Infection | Phase 2, Phase 3 | Status: RECRUITING